[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease.

Por Booij, J, Tissingh, G, Boer, G J, Speelman, J D, Stoof, J C, Janssen, A G, Wolters, E C, van Royen, E A
Publicado em 1997

Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson’s disease: the LEAP-study

Por Verschuur, Constant V. M., Suwijn, S. R., Post, B., Dijkgraaf, M., Bloem, B. R., van Hilten, J. J., van Laar, T., Tissingh, G., Deuschl, G., Lang, A. E., de Haan, R. J., de Bie, R. M. A.
Publicado no BMC Neurol (2015)